Grant: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
The Governing Council of the University of Toronto
$100,000.00
Latex agglutination tests for rapid, instrument-free COVID-19 diagnostics in saliva
FY 2020-21 · 2020-09-01
Summary
The team aims to develop latex agglutination tests (LATs) that will allow for the detection of SARS-CoV-2 virus (to assess infection) and host antibodies to SARS-CoV-2 (to assess immunity) in saliva samples. The LATs will be completed in a single step, the results will be readable by visual inspection, and the tests will be completed in less than 5 minutes. Assay reagents will be tuned and optimized for lyophilization and storage (in formulations including custom stabilization reagent mixtures), such that they can be incorporated into NRC saliva collection and inspection cartridges at low cost. When complete, the new systems have the potential to revolutionize current COVID-19 testing protocols, allowing rapid and reliable testing at home, in airports, at border crossings, in long-term care facilities, and beyond.
Department
Program
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
Academia
Business Number
108162330
Type
Grant
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2020-11-30
Agreement Number
955869
Agreement Start Date
2020-09-01
Agreement Title
Latex agglutination tests for rapid, instrument-free COVID-19 diagnostics in saliva
Agreement Title (French)
Tests d’agglutination au latex pour le dépistage rapide et sans instrument de la COVID-19 dans la salive
Agreement Type
Grant
Agreement Value
$100,000.00
Amendment Number
0
Description
The team aims to develop latex agglutination tests (LATs) that will allow for the detection of SARS-CoV-2 virus (to assess infection) and host antibodies to SARS-CoV-2 (to assess immunity) in saliva samples. The LATs will be completed in a single step, the results will be readable by visual inspection, and the tests will be completed in less than 5 minutes. Assay reagents will be tuned and optimized for lyophilization and storage (in formulations including custom stabilization reagent mixtures), such that they can be incorporated into NRC saliva collection and inspection cartridges at low cost. When complete, the new systems have the potential to revolutionize current COVID-19 testing protocols, allowing rapid and reliable testing at home, in airports, at border crossings, in long-term care facilities, and beyond.
Description (French)
L’équipe vise le développement de tests d’agglutination au latex qui permettront la détection du virus SARS-CoV-2 (et une éventuelle infection) et des anticorps de l’hôte (et donc une éventuelle immunité) dans des échantillons de salive. Les tests d’agglutination au latex seront administrés en une seule étape et les résultats seront lisibles par inspection visuelle en moins de 5 minutes. Les réactifs seront adaptés et optimisés pour la lyophilisation et le stockage (dans des formulations qui incluront un mélange de stabilisants spécifiques) de manière à pouvoir être incorporés à faible coût dans les cartouches de collecte et d’analyse de la salive mises au point par le CNRC. Une fois mis au point, ces systèmes de dépistage pourraient révolutionner les protocoles actuels de suivi de la COVID-19 et permettre des diagnostics rapides et fiables à domicile, dans les aéroports, aux postes-frontière, dans les établissements de soins à long terme et dans d’autres lieux.
Expected Results
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Expected Results (French)
À court terme, les résultats prévus seront des collaborations renforcées entre l'industrie, le milieu universitaire et le gouvernement pour soutenir l'excellence en recherche. À moyen terme, les résultats attendus seront le développement de nouvelles technologies potentiellement perturbatrices avec des collaborateurs. À long terme, trouver des solutions collaboratives aux défis des politiques publiques et créer des systèmes d'innovation plus solides.
Federal Riding
University–Rosedale
Federal Riding (French)
University–Rosedale
Federal Riding Number
35110
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Name (French)
Programme de collaboration en science, en technologie et en innovation - Initiatives de collaboration en R-D
Program Purpose
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
Program Purpose (French)
Collaborer à des programmes multipartites de recherche-développement dans le but de profiter de la synergie entre la recherche transformatrice à haut risque et à haut rendement et le potentiel de découvertes scientifiques et de percées technologiques révolutionnaires dans des secteurs d’intervention prioritaires.
Recipient Business Number
108162330
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
The Governing Council of the University of Toronto
Recipient Postal Code
M5G 1L5
Recipient Province or Territory
ON
Recipient Type
S
Reference Number
172-2020-2021-Q2-955869